Organigram Global Inc.OGINASDAQ

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Latest News

businesswire.com

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “Circular”) and related materials (the “Meeting Materials”) for its annual and special meeting (the “Meeting”) of the holders of its common shares (the “Shareholders”) to be held on March 30, 2026. The Circular is available under Organigram's profile on SEDAR+ at ww.

businesswire.com

Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1 is pleased to announce the launch of SHRED Shotz, a compact, single-serve 65ml cannabis beverage powered by FAST™, Organigram's fast-acting nanoemulsion technology platform designed to deliver a 15-minute onset2. This launch reflects Organigram's focus on differentiated innovation while leveraging the scale of SHRED, one of the Company's best-.

marijuanastocks.com

3 Canadian Marijuana Stocks To Diversify Your Stock Portfolio

Marijuana stocks, even with their volatile behavior, still offer diverse investment opportunities. Not every sector or company deals directly with the plant, so investors see this as an opportunity to capitalize. Now, even with that said, MSO and companies that work directly with the plant tend to capture more market share. Also, they are usually the first to see a run in trading when the time comes.

businesswire.com

Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) today announced the expansion of its international product portfolio, with the launch of Edison and BOXHOT medical cannabis vape and pastille products in Australia. Australia has become one of the world's most dynamic medical cannabis markets, with increasing approvals for access and prescribers utilising a broader range of dosage forms1. While flower remains a core category, alternatives such as vapes and pastille.

businesswire.com

Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading global cannabis company, today announced that it has entered into a subscription agreement (the “Subscription Agreement”) with BT DE Investments Inc. ( “BAT”), a wholly-owned subsidiary of British American Tobacco p.l.c. (LSE: BATs and NYSE: BTI), in connection with its previously announced proposed acquisition (the “Acquisition”) of Sanity Group GmbH (“Sanity” or “Sanity Group”.

businesswire.com

Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has entered into a definitive agreement (the “Purchase Agreement”) to acquire (the “Acquisition”) all the issued and outstanding shares of Sanity Group GmbH (“Sanity” or “Sanity Group”) not currently owned by Organigram. Upon closing of the Acquisition, Organigram will pay shareholders of Sanity (collectively, the “Ve.

marijuanastocks.com

3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026

What is it about the cannabis industry that keeps investors searching for top marijuana stocks to buy? Cannabis started as one of the first waves of peace, love, and rebellion towards many cultural injustices. Today, those same principles are the foundation in spirit. But the evolution of legal cannabis changed the culture forever. In 2026, significant changes have occurred and continue to happen. We have a battle for who will take over, will it be corporate cannabis or will the true cul;tiovaots be able to take back the industry.

seekingalpha.com

Organigram Global Is Now A Strong Buy

Organigram is upgraded to Strong Buy despite Q1 revenue and EBITDA missing estimates, citing long-term value and strategic positioning. OGI trades at a low 7.8x CY26 projected EBITDA and 1.1x tangible book value, reflecting limited downside for a debt-free, legally operating company. Strategic partnerships with British American Tobacco and international expansion targets—especially in Germany, Australia, and Israel—support growth prospects.

seekingalpha.com

Organigram Global Inc. (OGI:CA) Q1 2026 Earnings Call Transcript

zacks.com

OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates

OrganiGram (OGI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.05 per share a year ago.

businesswire.com

Organigram Reports First Quarter Fiscal 2026 Results

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 (“Q1 Fiscal 2026” or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-.

businesswire.com

Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call,.

businesswire.com

Organigram Extends Innovation Investment with Phylos

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, today announced the expansion of its innovation investment in Phylos Bioscience Inc. (“Phylos”), securing Organigram's position as a leader in seed-based cannabis genetics. Through an amended loan and product agreement, Organigram gains priority access to Phylos' autoflower genetics pipeline, including preferential economic terms and long-ter.

seekingalpha.com

Organigram: Premium Pivot Signals Further Margin Expansion

Organigram reported solid Q4 earnings, highlighted by achieving a record gross margin and issuing a net revenue guidance implying sustained double-digit organic growth. Quebec's recent vape launch could boost Organigram's Canadian market share, while consumer shift to quality experiences could boost sales of higher-margin liquid diamond vapes. Organigram's expanded capacity and adoption of seed-based cultivation reduce its cost per gram while offering opportunities to increase exports to higher-margin international markets.

seekingalpha.com

Organigram Global Inc. (OGI:CA) Q4 2025 Earnings Call Transcript

zacks.com

OrganiGram (OGI) Reports Q4 Loss, Beats Revenue Estimates

OrganiGram (OGI) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.04 per share a year ago.

businesswire.com

Organigram Reports Record Fourth Quarter and Fiscal 2025 Results

TORONTO--(BUSINESS WIRE)--Organigram Global Inc (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 (“Q4 Fiscal 2025” or "Fiscal 2025"). All financial information in this press release is expressed in Canadian dollars ("$"). FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS Gross Revenue: $123.3 million (+76% year-over-year). Net Reven.

businesswire.com

Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, announced today it will report earnings results for its fourth quarter fiscal 2025 ended September 30, 2025, on Tuesday, December 16, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, December 16, 2025 Time: 8:00 am Eastern Time To register for the conference cal.

businesswire.com

Organigram Announces Appointment of Chief Executive Officer

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company's new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of di.

seekingalpha.com

Sell Village Farms And Buy Organigram

Organigram upgraded to Buy and Village Farms downgraded to Strong Sell, reflecting shifts in fundamentals and valuation. OGI stands out for its strong balance sheet, strategic partnership with BTI, and potential for margin expansion, despite near-term risks. VFF has surged 356% year-to-date, but concerns over its rapid run-up, lack of guidance, and potential Texas disappointment justify a cautious outlook.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance